PT-112 in Subjects With Thymoma and Thymic Carcinoma

Clinical trial NCT05104736 · RECRUITING

Trial details

NCT number: NCT05104736
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Thymic Epithelial Tumor Recurrent Thymoma Thymic Cancer

Start date: 2022-04-06
Primary completion: 2027-12-31
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.